However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Pure Essence, a dietary supplement company offers Candex, a mixture of potent enzymes, which break down the substances that make up the cell walls of Candida yeast.
Increasing opioid abuse in North America is expected to boost the market growth
North America is expected to hold dominant position in the global vaginal fungi infections treatment market, owing to burden of recurrent vulvovaginal candidiasis in this region. For instance, according to The Lancet, an article published in August 2018, reports that in the U.S. there were 3,775 and 3,897 base case prevalence per 100,000 females in the U.S. and Canada respectively.
Moreover, increasing acquisitions by key players in the region is expected to drive the market growth during the forecast period. For instance, in February 2019, Aurobindo Pharma Limited acquired commercial operations and certain supporting infrastructure of Apotex Inc. in five European countries.
Vaginal Fungi Infections Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients